Vimentin and ASMA are applied as markers for mesenchymal or transformed cells, in our case of cancer associated fibroblasts or transformed tumour cells due to epithelial to mesenchymal transition (Fig. 2A,B). The gene discussed is VIM; the disease is cancer.